Clinical and Radiographic Evaluation of NIPSA Versus M-MIST in Treatment of Intra-osseous Defects
1 other identifier
interventional
40
1 country
1
Brief Summary
The aim: Clinical and Radiographic Evaluation for intra-osseous defects in stage III periodontitis using NIPSA versus M-MIST Steps in short Pre-surgical therapy
- Before surgical intervention, each patient will be given careful instructions on proper oral hygiene measures. Surgical Procedures:
- Group B (Control): Patients will receive Modified Minimally Invasive Surgical technique (M-MIST) Group A (Test): Patients will receive Non-Incised Papilla Surgical Approach (NIPSA) Postoperative medication
- Administration of amoxicillin (500 mg tabs) T.I.D for 7 days and Metronidazole (500 mg tabs) T.I.D for 7 days
- Rinsing with Chlorhexidine 0.12% (B.I.D for 14 days).
- Ibuprofen 600 mg tabs once every 8h could be administrated in case of unbearable pain
- Follow up period: after 8 weeks/ after surgery by 1 week- 1 month- 3 months- 6 months- 1 year
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2019
CompletedFirst Posted
Study publicly available on registry
November 4, 2019
CompletedStudy Start
First participant enrolled
May 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedNovember 4, 2019
October 1, 2019
1.6 years
October 20, 2019
October 31, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of CAL gain
Clinical attachment Level gain (CAL) by UNC Periodontal probe (mm)
baseline/ after 6 months & 1 year post-surgical
Secondary Outcomes (3)
Assessment of PD reduction
1 year
gingival recession
1 year
radiographic bone fill.
1 year
Study Arms (2)
Modified Minimally Invasive Surgical Technique
ACTIVE COMPARATORComparator: Modified Minimally Invasive Surgical Technique The defect will be gained through the tiny buccal triangular flap: from the buccal 'window' the soft tissue filling the defect (i.e. the so-called granulation tissue) will be sharply dissected from the papillary supra-crestal connective tissue and from the bony walls with a micro-blade and will be removed with a mini-curette (The soft tissue will be sharply dissected from the osseous defect)
Non- incised papilla surgical approach
OTHERintervention: Non- incised papilla surgical approach Apical horizontal incision on the buccal mucosa, as far as possible from the interdental papillae and marginal KT will be performed. Soft tissue will be reflected apico-coronally by a full-thickness flap showing the granulation tissue filling the bony defect after exposing the coronal limit of the intra-bony component of the defect, while the marginal tissue will be kept unaltered.
Interventions
patients received Non- incised papilla surgical approache
patients received Modified Minimally Invasive Surgical Technique
Eligibility Criteria
You may qualify if:
- Stage III periodontitis patient having at least one tooth with Two walls or combined 2- to 3-walls intraosseous defects ≥ 3 mm deep (assessed by trans-gingival probing, radiographic examination) with clinical attachment level (CAL) ≥ 5mm and pocket depth (PD) ≥ 6 mm.
- Defect not extended to a root furcation area.
- Vital teeth
- Non-smokers.
- No history of intake of antibiotics or other medications affecting the periodontium in the previous 6 months.
- No periodontal therapy carried out in the past 6 months.
- Able to sign an informed consent form.
- Patients age between 20 and 60 years old.
- Patients who are cooperative, motivated, and hygiene conscious.
- Able to come for the follow up appointment's needed.
- Systemically free according to Modified Cornell Medical Index health questionnaire (Kark et al., 1964).
You may not qualify if:
- Pregnancy or breast feeding.
- The presence of an orthodontic appliance.
- Teeth mobility greater than grade I.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo Unv
Cairo, 02, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Single blinded: * Blinding of the participants is not applicable. * Blinding of the operator is not applicable. * Outcome assessor (primary and secondary outcomes) \& biostatistician will be blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer assistant
Study Record Dates
First Submitted
October 20, 2019
First Posted
November 4, 2019
Study Start
May 1, 2020
Primary Completion
December 1, 2021
Study Completion
October 1, 2022
Last Updated
November 4, 2019
Record last verified: 2019-10